These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12724216)
1. The development of CpG island methylation biomarkers using restriction landmark genomic scanning. Smiraglia DJ; Plass C Ann N Y Acad Sci; 2003 Mar; 983():110-9. PubMed ID: 12724216 [TBL] [Abstract][Full Text] [Related]
2. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). Smiraglia DJ; Smith LT; Lang JC; Rush LJ; Dai Z; Schuller DE; Plass C J Med Genet; 2003 Jan; 40(1):25-33. PubMed ID: 12525538 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India. Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Wang SS; Smiraglia DJ; Wu YZ; Ghosh S; Rader JS; Cho KR; Bonfiglio TA; Nayar R; Plass C; Sherman ME Cancer Res; 2008 Apr; 68(7):2489-97. PubMed ID: 18381458 [TBL] [Abstract][Full Text] [Related]
5. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Smiraglia DJ; Rush LJ; Frühwald MC; Dai Z; Held WA; Costello JF; Lang JC; Eng C; Li B; Wright FA; Caligiuri MA; Plass C Hum Mol Genet; 2001 Jun; 10(13):1413-9. PubMed ID: 11440994 [TBL] [Abstract][Full Text] [Related]
6. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187 [TBL] [Abstract][Full Text] [Related]
7. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue. Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813 [TBL] [Abstract][Full Text] [Related]
9. Predicting aberrant CpG island methylation. Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846 [TBL] [Abstract][Full Text] [Related]
10. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis. Park J; Brena RM; Gruidl M; Zhou J; Huang T; Plass C; Tockman MS Cancer Biomark; 2005; 1(2-3):193-200. PubMed ID: 17192040 [TBL] [Abstract][Full Text] [Related]
11. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Rauch T; Wang Z; Zhang X; Zhong X; Wu X; Lau SK; Kernstine KH; Riggs AD; Pfeifer GP Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5527-32. PubMed ID: 17369352 [TBL] [Abstract][Full Text] [Related]
12. Infrequent occurrence of age-dependent changes in CpG island methylation as detected by restriction landmark genome scanning. Tra J; Kondo T; Lu Q; Kuick R; Hanash S; Richardson B Mech Ageing Dev; 2002 Sep; 123(11):1487-503. PubMed ID: 12425956 [TBL] [Abstract][Full Text] [Related]
13. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Smiraglia DJ; Plass C Oncogene; 2002 Aug; 21(35):5414-26. PubMed ID: 12154404 [TBL] [Abstract][Full Text] [Related]
14. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis. Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843 [TBL] [Abstract][Full Text] [Related]
15. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer. Misawa K; Kanazawa T; Misawa Y; Imai A; Endo S; Hakamada K; Mineta H Cancer Biomark; 2011-2012; 10(3-4):135-44. PubMed ID: 22674299 [TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
18. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation. Bastian PJ; Yegnasubramanian S; Palapattu GS; Rogers CG; Lin X; De Marzo AM; Nelson WG Eur Urol; 2004 Dec; 46(6):698-708. PubMed ID: 15548435 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185 [TBL] [Abstract][Full Text] [Related]
20. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer. Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]